318
Views
14
CrossRef citations to date
0
Altmetric
Articles

Enhancing immunotoxin cell-killing activity via combination therapy with ABT-737

, , , , , , , , , & show all
Pages 79-81 | Published online: 23 May 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Katja Simon-Keller, Stefan Barth, Angela Vincent & Alexander Marx. (2013) Targeting the fetal acetylcholine receptor in rhabdomyosarcoma. Expert Opinion on Therapeutic Targets 17:2, pages 127-138.
Read now

Articles from other publishers (13)

Radwa N Morgan, Sarra E Saleh, Hala A Farrag & Khaled M Aboshanab. (2023) New insights on Pseudomonas aeruginosa exotoxin A-based immunotoxins in targeted cancer therapeutic delivery . Therapeutic Delivery 14:1, pages 31-60.
Crossref
Belay Zeleke Sibuh, Rekha Gahtori, Noura Al-Dayan, Kumud Pant, Bahareh Farasati Far, Asrar Ahmad Malik, Ashish Kumar Gupta, Soumi Sadhu, Sushil Dohare & Piyush Kumar Gupta. (2022) Emerging trends in immunotoxin targeting cancer stem cells. Toxicology in Vitro 83, pages 105417.
Crossref
Jiajia Pan, Nan Li, Alex Renn, Hu Zhu, Lu Chen, Min Shen, Matthew D. Hall, Min Qian, Ira Pastan & Mitchell Ho. (2022) GPC1-Targeted Immunotoxins Inhibit Pancreatic Tumor Growth in Mice via Depletion of Short-lived GPC1 and Downregulation of Wnt Signaling. Molecular Cancer Therapeutics 21:6, pages 960-973.
Crossref
Roland B. Walter. 2015. Resistance to Immunotoxins in Cancer Therapy. Resistance to Immunotoxins in Cancer Therapy 75 87 .
Hannes Brehm, Judith Niesen, Radoslav Mladenov, Christoph Stein, Alessa Pardo, Georg Fey, Wijnand Helfrich, Rainer Fischer, Stefan Gattenlöhner & Stefan Barth. (2014) A CSPG4-specific immunotoxin kills rhabdomyosarcoma cells and binds to primary tumor tissues. Cancer Letters 352:2, pages 228-235.
Crossref
Antonella Antignani, Robert Sarnovsky & David J. FitzGerald. (2014) ABT-737 Promotes the Dislocation of ER Luminal Proteins to the Cytosol, Including Pseudomonas Exotoxin. Molecular Cancer Therapeutics 13:6, pages 1655-1663.
Crossref
Zhenhong Ni, Bin Wang, Xufang Dai, Wen Ding, Ting Yang, Xinzhe Li, Seth Lewin, Liang Xu, Jiqin Lian & Fengtian He. (2014) HCC cells with high levels of Bcl-2 are resistant to ABT-737 via activation of the ROS?JNK?autophagy pathway. Free Radical Biology and Medicine 70, pages 194-203.
Crossref
Alan S. Wayne, David J. FitzGerald, Robert J. Kreitman & Ira Pastan. (2014) Immunotoxins for leukemia. Blood 123:16, pages 2470-2477.
Crossref
V Maevis, U Mey, G Schmidt-Wolf & I G H Schmidt-Wolf. (2014) Hairy cell leukemia: short review, today’s recommendations and outlook. Blood Cancer Journal 4:2, pages e184-e184.
Crossref
Abid R. Mattoo, Ira Pastan & David FitzGerald. (2013) Combination Treatments with the PKC Inhibitor, Enzastaurin, Enhance the Cytotoxicity of the Anti-Mesothelin Immunotoxin, SS1P. PLoS ONE 8:10, pages e75576.
Crossref
Antonella Antignani & David FitzGerald. (2013) Immunotoxins: The Role of the Toxin. Toxins 5:8, pages 1486-1502.
Crossref
Ryan C. Thompson, Iosif Vardinogiannis & Thomas D. Gilmore. (2013) The Sensitivity of Diffuse Large B-Cell Lymphoma Cell Lines to Histone Deacetylase Inhibitor-Induced Apoptosis Is Modulated by BCL-2 Family Protein Activity. PLoS ONE 8:5, pages e62822.
Crossref
Kristin R. Lamont, Muneer G. Hasham, Nina M. Donghia, Jane Branca, Margaret Chavaree, Betsy Chase, Anne Breggia, Jacquelyn Hedlund, Ivette Emery, Francesca Cavallo, Maria Jasin, Jens Rüter & Kevin D. Mills. (2013) Attenuating homologous recombination stimulates an AID-induced antileukemic effect. Journal of Experimental Medicine 210:5, pages 1021-1033.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.